Search Orphan Drug Designations and Approvals
-
Generic Name: | Ombitasvir/Paritaprevir/Ritonavir |
---|---|
Date Designated: | 02/24/2016 |
Orphan Designation: | Treatment of pediatric patients with chronic hepatitis C virus infection |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 05/15/2020 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
AbbVie Inc. 1 North Waukegan Road North Chicago, Illinois 60064 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-